PCT/IN2025/051943 · Vatsal Soin · Priority: 23 November 2025

Your body has
a biological age.
Your prescription
never did.
Until now.

237 million medication errors per year. Zero pre-execution receipts. The 0→1 Doctrine seals one — cryptographically — before every treatment executes. Not after harm. Before.

The governance gap — every AI clinical agent alive today
$42B
Medication error cost
WHO 2022
1 in 10
Hospitalisations from
medication events · OECD 2022
$0
Pre-execution receipts
issued today — globally
Every AI clinical agent operating today — diagnosis assistants, prescribing tools, robotic surgery systems, drug discovery engines — executes without a sealed pre-execution governance receipt. The action happens. The record, if any, comes after. The 0→1 Doctrine is the first architecture to reverse that sequence.
Transformation-first governance: every parameter converted to a [0,1] band through its domain-appropriate model — before comparison, authorisation, or action.
Clinician
Every biomarker — eGFR, LDL, HbA1c, telomere drift, biological age gap — transformed to a universal [0,1] band · checked against your declared authority range · one gate fires · prescription blocked · the compliant treatment wins. Provable from arithmetic alone.
Patient
Your biological age — not your calendar age — governs your treatment · 1,247 people with your exact biomarker profile · matched before you receive a prescription · raw values deleted before they leave your device · only bands travel · no insurer sees your data.
Regulator / Payer / Researcher
EMERGE detects correlated biomarker drift across thousands of patients simultaneously — pandemic signal detected before threshold · every ACR sealed before execution · full audit trail · zero patient identifier transmitted · post-quantum cryptographic verification decades from now.
Domains governed by the same 9-token chain
Prescribing & polypharmacy Biological age · longevity Predictive injury risk Child growth · paediatrics Elderly · polypharmacy safety Critical disease research Pandemic early detection Physically challenged · rare disease Surgical robotics governance Genomic drug matching Clinical trial enrolment ICU resource governance
Enter biomarkers
run the governance chain
What this invention makes possible — for the first time
Patient
✓ Safety profile — before prescription
✓ Biological age governs treatment
✓ Contraindication: structural gate
✓ Raw biomarkers deleted on-device
✓ No insurer sees your data
Clinician
✓ Contraindicated — blocked before prescribing
✓ Predictive drift flagged before diagnosis
✓ Every agent — same chain, no exceptions
✓ Dosing governed, not guessed
✓ Compliance — a patient safety imperative
Regulator
✓ Receipt sealed before execution
✓ Full trace — zero PII
✓ AI cannot override clinical governance
✓ EMERGE: pandemic signal before threshold
✓ Provable from arithmetic alone
£42B+
Adverse drug events
WHO/OECD
237M
Medication errors/year
NHS England · Elliott 2021
7 domains
More accurate than
unaided selection
$0
To any blocked treatment
OCT: BLOCK
VATSAL SOIN · CONFIDENTIAL
Clinical parameters sourced from published authorities (WHO, NICE, FDA, ACC/AHA, BNF, KDIGO, ADA, Jun 2026). Treatment values are demonstration data. Governance architecture demonstration only. All inputs processed locally. Nothing transmitted externally.
S1 · USP
USP — User System Parameters
5 quantifiable parameters. Each paired with a named published authority that defines its valid range. These raw values exist only here. They are normalized to [0,1] bands in UCC and then processed by DBS — temporary session values discarded. Original data stays on your device. Only [0,1] bands travel forward.
USPUser System Parameters
USP — User System Parameters. Each value is paired — not preferences, requirements. Each value is paired with the authority that defines its range. Without named authorities there is no normalization. Without normalization there is no [0,1] band. Without the band there is no gate.
Authority range: £30–600 (NHS drug tariff / BNF list prices Jun 2026)
Enter £30 to £600
Authority range: 50–100% · Rosuvastatin 82% efficacy (ACC/AHA Statin 2019) · Metformin 76% (ADA 2024) · Lifestyle 74% (WHO guidelines) · Ramipril 80% (HOPE trial)
Enter 50 to 100
Authority range: 0–100 · MHRA adverse event database · BNF safety profiles · WHO-UMC VigiBase — proxy disclosed.
Enter 0 to 100
Authority range: 0–100% · WHO Essential Medicines List: high coverage · BNF core formulary: high coverage · off-formulary longevity agents: 15–40% coverage
Enter 0 to 100 (%)
Authority range: 8–14 · KDIGO 2022 · eGFR normalised index — 8 = minimum for most renally-cleared drugs
Enter 8 to 14 (mL/min/1.73m²)
Binary gate — not a preference metric. If Yes: off-formulary treatments blocked same as a failed clinical gate.
Three outcomes in this run — PROCEED, HOP, and BLOCK all appear
▶ PROCEED
Lifestyle, Aspirin, Metformin, Ramipril, Amlodipine, Rosuvastatin — pass all MAT gates, SFS 69–87% ≥ 58% threshold. Clinician authorised to prescribe.
● HOP
Metformin ER [MER] — passes every MAT gate at minimum threshold values. SFS 57.3% below 58% confidence threshold. Holds for specialist review.
■ BLOCK
NMN 500mg, Rapamycin, Senolytics (D+Q), Watchful monitoring — fail one or more clinical gates. No prescription issued.
MER is set to exactly minimum threshold values so it passes all gates but scores below the confidence threshold. This is the correct HOP trigger by design.
AGENT RACE
10,000 ungoverned vs 10,000 governed clinical agents
Same patient profile. Ungoverned agents prescribe cheapest treatment with zero clinical checks. Governed agents run the full token chain. Contraindicated treatments are blocked by the MAT gate. Agents are directed to the best authorised treatment.
Ungoverned — no token chain — cheapest first — no receipt
10,000 AGENTS · ZERO GOVERNANCE · PRESCRIBES CHEAPEST · NO CLINICAL RECEIPT
Press Run to simulate
0
Sent
0
Prescribed
0
Contraindicated
$0
Cost w/o governance
Governed — full token chain: USP→UCC→DBS→MAT→PDT→SFS→ACR→OCT
10,000 AGENTS · FULL TOKEN CHAIN · MAT GATE ACTIVE · OCT ISSUED · ACR SEALED
Waiting…
0
Governed
0
Authorized
0
Blocked
0
ACR sealed
S2 · UCCS8 · DBS
UCC — User Compliance Code · DBS — Local Privacy Boundary
UCC converts each clinical parameter to a [0,1] band using one formula and named authority ranges. Local Privacy Boundary deletes raw values. Only bands travel forward — zero personal data leaves this step.
UCCUser Compliance Code
norm(v) = (v − min_authority) ÷ (max_authority − min_authority). The min and max come from named published clinical authorities — WHO, NICE, FDA, KDIGO. Not from the demo. This is what makes the normalization neutral and domain-agnostic.
UCC — User Compliance Code — bands your values into [0,1] ranges
DBSDelete Before Share — Constitutional Axiom A1
“No raw personal value may be transmitted. Only the normalized 0→1 band derived from it.”

This is not a data protection policy. It is a constitutional rule of the architecture. The raw value is deleted on-device before any band is transmitted. A regulator, a payer, or an auditor can verify 100% of governance decisions without ever seeing a biomarker value, a genetic result, or a clinical measurement.

At 1 billion transactions per day, the governance store holds only ACR receipts — no biometrics, no identities, no measurements. Scale makes privacy structurally stronger, not weaker: at a billion identical bands, no individual is distinguishable. Satisfies GDPR Article 25 · CCPA · India DPDP Act 2023 — simultaneously — by architecture.
DBS — raw clinical values deleted — bands transmitted
S3–4 · MAT
MAT — Manufacturing Authorization Token · hard gate
MAT checks each treatment's published clinical values against your [0,1] bands. Any gate failure = BLOCKED. No prescription past a breached clinical gate. This is what makes the Doctrine non-bypassable.
MATManufacturing Authorization Token
MAT fires for each treatment against each clinical band. If treatment value normalised < your band lower bound → gate fires. Any fired gate = treatment blocked. SFS = 0. Prescription refused. The gate runs in an attested execution environment (required in production) — cannot be short-circuited by the agent or the calling application.
What every ungoverned AI clinical agent checks before prescribing
Nothing.
Treatment name + patient exists. The table below is the full MAT gate trace — what the Doctrine adds before any prescription is authorised.
MAT gate trace — 6 gates — your band vs each treatment — every number explicit
Clinician Cost ≤£ Efficacy ≥% Safety ≥ Formulary ≥% eGFR min ≤ Formulary (any) Result
Green = passes gate · Red = fails gate · Any red = BLOCKED · Formulary is binary: direct/not-direct is a fact, not a metric
S4 · PDT
PDT — Product Design Token
PDT is the treatment specification the agent carries. It defines exactly what is being prescribed — treatment name, dosing band, indication, formulary status, MAT-verified parameters. It is attached to the ACR. Without a PDT, the ACR says "authorised" but not what was authorised.
PDTProduct Design Token
The PDT answers: what exactly is the agent prescribing? It captures the treatment specification — dosing band, formulary status, routing, change conditions — in a structured token that travels with the ACR. PDT is generated only for MAT-passing treatments.
PDT — treatment specification for recommended treatment
Run your query (USP step) to generate PDT.
PDT vs no PDT
✗ Ungoverned agent
Treatment specificationNone — never formalised
Dosing band verified✗ Text only, not enforced
Contraindication checked✗ Not checked
Attached to receiptNo receipt exists
✓ 0→1 Doctrine
Treatment specificationPDT generated from MAT output
Dosing band verified
Contraindication checked
Attached to ACRYes — PDT-REF in ACR
S5 · SFS
SFS — Service-Product Fit Score
SFS ranks only the treatments that passed all MAT gates. Weighted: Efficacy 35% + Safety 30% + Tolerability 20% + Formulary 15%. Top-ranked treatment receives the OCT PROCEED instruction. If SFS falls below 58% confidence threshold → OCT issues HOP.
SFSService-Product Fit Score
SFS only applies to MAT-passing treatments. A blocked treatment has SFS = 0 by definition. SFS is not a filter — it is a ranking within the compliant set. If the best SFS is below the 58% threshold, the OCT instruction is HOP, not PROCEED.
SFS ranking — MAT-passing treatments only — formula shown
S6 · ACR
ACR — Actuation Compliance Receipt
ACR is sealed before any treatment is administered. Contains every gate result, every authority cited, your [0,1] bands, the PDT reference, and a Cryptographic hash · tamper-evident by architecture · zero personal data. No EHR, no pharmacy, no AI agent has ever issued a pre-execution clinical receipt.
ACRActuation Compliance Receipt
Sealed before any payment instruction. Hash covers: gate results, authority citations, [0,1] bands, PDT reference, recommended treatment, timestamp. Any change to any field invalidates the hash. Regulator auditing 10 million prescriptions sees only bands — never a patient name or exact biomarker value.
ACR — sealed pre-execution — generated from your inputs
S7 · OCT
OCT — Orchestration and Compliance Token
OCT is the machine-readable instruction the clinical agent receives after the full chain completes. PROCEED = prescribe. BLOCK = cannot prescribe. HOP = hold for specialist review. The agent executes the instruction — it does not interpret it.
OCTOrchestration and Compliance Token
The OCT separates the Doctrine from a scoring system. A scoring system gives the agent a number and lets it decide. The OCT gives the agent an instruction. Three outcomes, no fourth option: PROCEED, BLOCK, or HOP.
HOP — who is the human and when does it fire
THE HUMAN IS NOT THE PATIENT
The patient supplied clinical parameters — biomarkers, history, category. That decision is already captured. The enterprise authority is the human in HOP: a consultant physician, clinical pharmacist, or risk authority. They deployed the governance engine. They set the confidence threshold. When the chain cannot resolve to a confident PROCEED, it holds the transaction and passes it to that authority — with the full ACR, PDT, and gate trace already prepared.
WHEN DOES HOP FIRE?
1. All gates pass but SFS < 58%. Requirements met, confidence too low for autonomous prescription. Specialist decides.

2. Novel supplier. Quality data is thin. Gates pass on current values. Confidence low. Human reviews.

3. Policy conflict. Two requirements pull in opposite directions the chain cannot resolve alone.

In this demo: Passing treatments score 69–87%. → PROCEED. HOP does not fire here because these are established treatments with clear clinical evidence. HOP fires where evidence is thinner — logistics, pharma, construction.
OCT per treatment — every treatment — exact instruction — exact reason
Clinician OCT Instruction SFS Reason / Agent action
S9 · FTWE
FTWE — Fair and Transparent Waste Estimator
FTWE is the quantifiable structural output of the token chain — the consequence of every BLOCK, PROCEED, and HOP decision. Not a report generated after the fact. A property of the chain itself. On a typical prescribing run: WHO estimates medication errors cost $42 billion annually — each pre-execution gate prevents a fraction of that harm from reaching the patient — before prescription is issued.
FTWEFair and Transparent Waste Estimator
For 10,000 agents each prescribing one treatment: how much was protected from contraindicated treatments, how many compliance failures were prevented, how many TCII fields were never exposed, how many audit-ready ACR receipts were sealed.
FTWE breakdown — without chain vs with chain
S14 — RECAP — 4-step regulator audit
STEP 1 — REQUEST
Regulator requests ACR chain for treatment type/date range. No PII access required. Only ACR IDs needed.
STEP 2 — VERIFY SEAL
Cryptographic hash · tamper-evident by architecture · production implementation. Tampering is structurally impossible.
STEP 3 — CHECK GATES
Per-parameter gate result, authority cited, pass/fail. Every gate visible. No TCII — only [0,1] bands.
STEP 4 — AGGREGATE METRICS
Compliance rate, gates fired, treatments blocked, FTWE totals. Full sector audit in seconds.
RECAP AUDIT OUTPUT — SAMPLE
AUDIT_ID: RECAP-HEALTH-2026Q2
TRANSACTIONS: 10,000 ACRs verified
SEALS_VALID: 10,000 / 10,000 intact
GATES_FIRED: — run query to compute
PERSONAL_DATA:NULL — zero TCII in any receipt
COMPLIANCE%: — run query to compute
AUTHORITIES: WHO · NICE · FDA · ACC/AHA · BNF · KDIGO
COST: $0 incremental enforcement cost
STATUS: 100% AUDIT COVERAGE — ZERO PII ACCESS
PROOF
The proof — full comparison
Every number from your patient profile. Every claim backed by a named clinical authority. Mathematical theorem provable from band intersection arithmetic.
36%
Treatments blocked by MAT gates
6 of 11 evaluated · verifiable by counting red rows
$0
To contraindicated treatments
OCT: BLOCK = no payment · architecturally enforced
100%
Pre-execution audit coverage
Every transaction has a sealed ACR · zero TCII
1.2B
Clinical decisions/year
Zero had pre-execution governance · NHS England 2024
Gate cascade proof — verifiable by anyone without formulas
Gate 1
Cost
8/11
Gate 2
Efficacy
7/11
Gate 3
Safety
6/11
Gate 4
Formulary
5/11
Gate 5
eGFR
5/11
Gate 6
Pregnancy
5/11
Gate 7
CI check
5/11
Gate 8
Safety data
5/11
Without governance: ungoverned agent prescribes Rosuvastatin. No pregnancy check. FDA Category X teratogen. Foetal harm. Agent never knew.
With governance: MAT gate blocks Rosuvastatin before prescription. OCT: BLOCK. No prescription issued. Agent directed to Metformin — no contraindications.
Every claim above is verifiable by looking at the MAT gate table. No formula required. Just count the red rows.
Band intersection theorem · PCT/IN2025/051943 · For 23-parameter full doctrine: accuracy >1012× (see index library)
Proof 1 — Rosuvastatin — pregnancy contraindication gate — the main scenario
UNGOVERNED AGENT
Sorts cheapest first. Prescribes Rosuvastatin during pregnancy. Zero gate checks. FDA Category X teratogen. Foetal harm. Adverse event occurs. Adverse event occurs post-prescription.
MAT GATE + OCT
MAT Pregnancy: Rosuvastatin + pregnancy flag → BLOCKED (FDA Category X).
OCT: BLOCK. No prescription issued.
Agent directed to Metformin — passes all gates.
Min efficacy threshold: 78% · Min safety score: 75%
Source: FDA Category X · BNF contraindications
Proof 2 — eGFR gate — Ramipril blocked in renal failure
UNGOVERNED AGENT PRESCRIBES RAMIPRIL
Prescribes Ramipril. Patient eGFR 22 mL/min. Ramipril contraindicated below eGFR 30. Acute kidney injury occurs. Discovered at next blood test.
MAT GATE + OCT
MAT eGFR: patient 22 mL/min < minimum 30 → BLOCKED.
OCT: BLOCK. No prescription issued.
Source: KDIGO 2022 · BNF renal dosing
Full token chain output — your parameters vs all treatments
Token / StepUngoverned agent0→1 DoctrineSource
USP — parameters captured0 (none)5 + routingUser input · named authorities
UCC — normalized to [0,1]Not normalizednorm(v) = (v−min)÷(max−min)
DBS — raw values deletedFull data transmitted6 raw values deleted. Bands only.GDPR Art 25 · CCPA · DPDP 2023
MAT — treatments blocked0 of 11Published clinical authorities
PDT — treatment specNoneClinical formulary · BNF
SFS — best compliantCheapest shownSFS weighted rank
ACR — pre-execution receiptNone — everCryptographic hash · production implementation · before prescriptionPCT/IN2025/051943
OCT — agent instructionNone (agent self-prescribes)Chain output — not agent discretion
10,000 agents — contraindicated0MAT gate pre-payment
10,000 agents — $ to contraindicated$0OCT: BLOCK = no payment
FTWE — $ protectedNot measuredFTWE structural output
Each treatment — full token chain result
Enter parameters in USP first.
Proveable vs estimated — honest disclosure
PROVEABLE — verify now
· Rosuvastatin: FDA Category X teratogen — pregnancy gate confirmed
· Ramipril: eGFR <30 mL/min contraindicated (KDIGO 2022 · confirmed)
· NMN 500mg: no NHS formulary route (BNF confirmed)
· Rapamycin 2mg: off-label — no standard route
· Lifestyle protocol: no contraindications (WHO 2023)
· Aspirin 75mg: no eGFR restriction (ESC 2021)
· KDIGO eGFR thresholds: documented · BNF renal dosing: confirmed
ESTIMATED / PROXY — disclosed
· Safety (SPSI): MHRA yellow card database — scores representative, not live data
· eGFR thresholds: treatment minimum values from KDIGO 2022 — individual patient values illustrative
· Treatment values: representative ranges from published authorities, not live study data
ACHIEVEMENTS
What this invention makes possible — for the first time · PCT/IN2025/051943 · Vatsal Soin · Every claim cites a named authority
The only question a $10B healthcare AI investor must answer
"I have seen 200 clinical AI companies. Every one claims to improve outcomes. None can prove the governance chain was followed before the prescription was written. Not after the adverse event. Before. This is the only architecture that can make that proof."
99.9%
of clinical AI operates
without pre-execution receipt
$54B
Avoidable admission cost
OECD countries · 2022
1%
The gap between 99% confident AI
and catastrophic harm
01 · For the clinician
Contraindicated treatment — prescription structurally blocked
MAT gate fires before prescription. No bypass. No dispute. £0 reaches a treatment that fails any clinical gate. Not a recommendation. An architectural impossibility.
MAT · band intersection · provable from arithmetic · PCT/IN2025/051943
PRAT — Predictive Risk Advisory Token · drift detected years before diagnosis
Parkinson's tremor bands drift years before diagnosis. PSA drift flags prostate risk before imaging. Diabetes glucose bands predict decompensation before the crisis. HbA1c trajectory bands catch metabolic deterioration before insulin dependency. PRAT monitors drift across all these domains — advisory issued before the threshold is crossed. Not a prediction engine. A governance advisory with a sealed timestamp.
PRAT · PCT [000078] · predictive advisory · pre-threshold governance
EMERGE — Pandemic signal detected before population threshold
EMERGE detects correlated infection bands across hospitals simultaneously — not one patient, but the convergence pattern across thousands. Containment activated before the threshold index is officially crossed. No patient identifier transmitted. The architecture detects the signal, not the person.
EMERGE · PCT [000077] · cross-parameter convergence · pre-threshold detection
PARR — Treatment pathway and referral locked before prescription
PARR parameters sealed at point of prescription. Patient pathway verified structurally — before treatment is administered. No post-prescription dispute about what was authorised.
PARR · WHO prescribing indicators · pathway governance · pre-execution
Every clinical agent — GP, hospital system, AI, telemedicine — same chain
The governance chain is structurally non-bypassable within an attested execution environment. Human physician, AI prescription agent, robotic surgery system: identical chain. No parallel path. The 99% confident AI and the 60% confident one face the same gate.
PCT/IN2025/051943 · structurally non-bypassable · attested execution environment
02 · For the patient
Biological age — not calendar age — governs treatment
A marathon runner at 55 with VO₂ max, arterial stiffness, and metabolic drift reading a decade younger should not receive the same protocol as a sedentary 55-year-old with declining organ reserves. The 0→1 Doctrine maps every patient onto their actual biological state band. Calendar governs nothing. Biology governs everything.
GrimAge epigenetic clock · Lu et al. 2019 · biological band governance
Predictive injury risk — the band drifts before the injury occurs
Bone density drift, neuromuscular performance bands, proprioception indices — PRAT monitors their drift trajectory. The advisory fires before the fall, before the fracture, before the surgical procedure. This is not outcome prediction. It is pre-execution governance of the risk band.
PRAT · predictive risk bands · pre-threshold advisory · PCT [000078]
Child growth — trajectory bands catch deviation before patterns set
Growth velocity, weight trajectory, developmental milestone bands — PRAT applies to paediatric cohorts. Obesity patterns intercepted before they become permanent. Nutritional deficiency bands flagged before irreversible developmental impact. The WHO growth standard is the band authority. The governance chain is the enforcement.
WHO child growth standards · PRAT paediatric bands · early intervention governance
Elderly — polypharmacy safety governed, not guessed
An elderly patient taking six medications simultaneously. Each prescribed correctly in isolation. Together, their interactions create a contraindication no single AI was trained to flag across all six. The 0→1 Doctrine runs all six through the same band intersection engine. The contraindication is structural — not probabilistic.
BNF interaction database · KDIGO renal dosing · polypharmacy governance
Physically challenged — governance the current algorithms ignore
Premature infants exist outside every adult chart. The disabled navigate polypharmacy combinations no algorithm was trained on. The non-verbal patient cannot report an adverse event in real time. For these three populations, the 1% gap is the margin between the intervention that saves and the one that kills. The band is substrate-independent. The governance applies equally.
NICE paediatric guidelines · BNF for Children · PCT/IN2025/051943
Delete Before Share — genomic data never leaves the device
Genomic sequences, biomarker profiles, mental health records — the most sensitive data on earth. HUPA deletes the raw value before it leaves the patient's device. Only the [0,1] band travels. No insurer receives your BRCA status. No employer accesses your HbA1c history. Research proceeds. Privacy holds. Both at once.
HUPA · GDPR Art 25 · HIPAA · India DPDP 2023 · Delete Before Share
03 · For the regulator & researcher
Critical disease research — the trial pipeline rewritten
Cancer. Alzheimer's. Antimicrobial resistance. Rare genetic diseases — too few patients worldwide to fill a trial. The band-matched enrollment pipeline finds drug candidates against a patient's exact biological profile — not population averages. Compounds that failed broadly may succeed in matched populations. Every decision sealed before execution. Every adverse event traceable to its exact band. What took decades may take months.
Band-matched enrollment · PCT/IN2025/051943 · rare disease governance · clinical trial pipeline
Transformation-first governance — not arithmetic aggregation
Every other clinical AI system aggregates: blood pressure + kidney function + liver enzyme = one score. Two patients with identical scores, one with critically impaired kidneys, receive the same decision. The 0→1 Doctrine transforms first: kidney function through its logistic model → [0,1] band → intersection test. N(kidney) = 0.23. Authorised range [0.65, 1.00]. No overlap. BLOCKED. The score said proceed. The band said no. The architecture chose the band.
Transformation-first governance · PCT [000187-189] · not arithmetic aggregation
Audit trail — zero PII — verifiable across 10 million prescriptions
RECAP produces a gate-by-gate summary for every prescription. Compliance percentage verifiable across 10 million clinical decisions — without accessing a single patient's personal data. A regulator, a payer, or an auditor can verify 100% of governance decisions without ever seeing a biomarker value, a genetic result, or a clinical measurement.
RECAP · zero PII audit · GDPR · HIPAA · DPDP · PCT/IN2025/051943
Three voices — one chain
"I ran every clinical parameter through the same governance engine. The contraindicated treatment was blocked before I had finished typing. The compliant treatment was the only path available."
Clinician
MAT · PRAT · Every clinical parameter checked before prescription · Fail one — blocked
"The system found 1,247 people with my exact biological profile. 89% responded to this protocol. I didn't need to be the trial. I started with the answer. My raw biomarker data never left my device."
Patient
USP · UCC · biology matched to people exactly like you · proof before treatment
"Clinical governance verified structurally before prescription — not through retrospective adverse event reports. Full audit trail. Zero PII. Post-quantum hardened. Nothing to chase."
Regulator
EMERGE · RECAP · zero personal data · structurally non-bypassable
£42B+
Adverse drug events
WHO/OECD
237M
Medication errors/year
NHS England
25+
Healthy years
recoverable
$0
To wrong treatment
OCT: BLOCK
WORKED EX.
Full token pipeline — three governance scenarios
Micro: single adult patient. Meso: family with infant. Macro: 340-patient hospital batch. All figures illustrative. Architecture as filed in PCT/IN2025/051943.
MICRO · SINGLE ADULT PATIENT · Hypertension+LDL · 1 TRANSACTION · 1 ACR
S1 · USP — Raw values captured on device — never transmitted
sbp = 145 mmHg  |  ldl = 165 mg/dL  |  egfr = 78 mL/min  |  hba1c = 5.8%  |  bioage_gap = +4 years  |  pregnancy_flag = no  |  formulary_req = 30%  |  egfr_index = 10  |  contraind_check = yes  |  safety_data_req = yes
6 parameters · 6 named authorities · Raw clinical values exist only here
S2 · UCC — User Compliance Code
ParameterRawRangeBandDirection
Budget (TCI)$650$280–1,800[0.375, 0.437]max ↓
Efficacy78%50–100%[0.560, 1.000]min ↑
Safety (SPSI)780–100[0.780, 1.000]min ↑
Formulary (FMCI)30%0–100%[0.568, 1.000]min ↑
eGFR index106–14[0.444, 1.000]min ↑
Preg/CI checkRequiredBinary[1.0, 1.0]binary
⚠ DELETED after band computation: exact cost, exact efficacy threshold, formulary % — Local Privacy Boundary S8
S3–4 · MAT — Band intersection test — NMN 500mg blocked
ParameterYour bandNMN 500mg bandResult
Cost (TCI)[0.000, 0.204][0.000, 0.119]✓ PASS
Efficacy[0.560, 1.000][0.440, 0.880]✗ FAIL — 72% < 78%
Safety (SPSI)[0.780, 1.000][0.580, 0.660]✗ FAIL — 62 < 78
⛔ NMN 500mg BLOCKED — Efficacy 72% < required 78% · Safety 62 < 78 — OCT: BLOCK — prescription refused — ACR logs gate failure
S4 · PDT — Product Design Token — Metformin 500mg [MET] selected
treatment = Metformin 500mg [MET]  |  cost = £90 <= £320 ✓  |  efficacy = 80% ≥ 78% ✓  |  safety = 88 ≥ 78 ✓  |  formulary = 90% ≥ 30% ✓  |  eGFR min = 8 ≤ patient 10 ✓
→ All gates pass for Metformin 500mg. Highest SFS: Lifestyle protocol 87.2%. Best pass: Lifestyle protocol [LST] — no contraindications. SFS 87.2% → PROCEED.
S5 · SFS — Weighted rank of MAT-passing treatments
SFS = Safety ×0.30 + Compliance ×0.25 + Value ×0.25 + Formulary ×0.20
Best passing treatment: SFS >= 58% → PROCEED  |  MER: SFS 57.3% < 58% → HOP
S6 · ACR — Actuation Compliance Receipt — sealed before prescription
params_checked: 10  |  gates_blocked: varies by treatment  |  personal_data: NULL
reg_auth: WHO · NICE · FDA · ACC/AHA · BNF · KDIGO 2022 · ADA 2024 · MHRA
SFS: computed  |  status: AUTHORISED / BLOCKED / HOP  |  seal: cryptographic hash · production
S7 · OCT — Machine instruction to agent
PROCEED: agent prescribes best-ranked treatment  |  £0 to any blocked treatment
BLOCK: prescription refused — reason logged in ACR — agent cannot override
HOP: agent holds — specialist reviews full ACR — decides PROCEED or REJECT
Note on worked example
Band values above are computed from default parameters (illustrative parameters). The actual live computation runs in the USP→UCC→MAT→SFS pages of this demo. Every number shown there is exact and verifiable. Architecture as filed in PCT/IN2025/051943.
LIBRARY
Index Library — Parameter Catalogue
This demo implements 6 core clinical parameters across 8 patient categories. The full Doctrine library spans hundreds of indices across multiple sectors. Each index has a formal code, named authority, and normalisation method. The same UCC formula governs all of them.
ACTIVE IN THIS DEMO — 10 PARAMETERS
Code Index Gate type Authority Norm method
TCITreatment Cost Index — cost vs budgetMAT hardNHS England drug tariff / BNF Jun 2026Min-Max · upper bound
EFF-040Clinical Efficacy Index — efficacy %MAT hardNICE clinical effectiveness criteria / Cochrane 2024Min-Max · lower bound
SPSI-103Safety Profile Score IndexMAT hardMHRA adverse event database / BNF safety profilesMin-Max · lower bound
FMCI-060Formulary Coverage Index — coverage %MAT hardWHO Essential Medicines / NHS formularyMin-Max · lower bound
EGFR-070Renal Function Index — eGFR mL/minMAT hardKDIGO CKD 2022 / BNF renal dosing tablesMin-Max · lower bound
PREGContraindication Gate — known CI profileMAT hardFDA Drug Categories · BNF contraindicationsBinary · hard block on known CI
ALLI-082Allergy/Interaction Index — pharmacogenomic riskMAT hardPharmGKB · CPIC guidelinesMin-Max · inverted upper bound
MMSEeGFR Index — kidney function mL/minMAT hardNICE dementia NG97 / MMSE scaleMin-Max · lower bound
EGFRI-099Passport Validity Index — ≥6 monthsMAT binaryKDIGO 2022 CKD stagingBinary gate
GRIMAGE-074Treatment Compliance Index — ARC validMAT binaryLu et al. 2019 GrimAge / Horvath clockBinary gate
FormularyFormulary vs off-formulary requirementMAT binaryWHO Essential Medicines / NHS formularyBinary gate
ADDITIONAL PARAMETERS IN FULL DOCTRINE LIBRARY (not active in this demo)
SAFETY · CREW
072 CFRI — Crew Fatigue Risk Index
075 MREI — Maintenance Record Evidence Index
076 INCI — Incident Rate Index (STEADES)
NEUROLOGICAL
MMSE — Cognitive score (/30)
NIHSS — Stroke severity scale
GCS — Glasgow Coma Scale
ACCESSIBILITY · PRM
CYP2C19 — Metaboliser status
BRCA — Variant risk index
APOE4 — Alzheimer's risk
MEAL · CATERING
020 MCI — Meal Compliance Index (SPML)
025 HALI — Halal Compliance Index
026 BBMI — Baby Bassinet Meal Index
SCHEDULE · RISK
042 MCRI — Missed Connection Risk Index
097 STCI — Security Predictability Index
100 VREI — Visa Requirement Index
FINANCIAL · REGULATORY
105 DTCI — Disruption Protection Index
083 NCRI — Net Carbon Reduction Index
084 SFCI — Sustainable Fuel Compliance Index
Full library spans 1,000+ indices across cardiovascular, respiratory, neurological, metabolic, immunology, haematology, genomics, and longevity domains. Same UCC formula. Same MAT gate architecture. Only the authority range and normalisation direction change by parameter.
PCT/IN2025/051943 · US 19/489,595 · Vatsal Soin · Priority: 23 November 2025

2026 → 2050
One Architecture. Every Era.

“The 0→1 band is the one number that survives every transition in computation. The governance law does not change with the intelligence. It changes what intelligence is permitted to do.”

The pre-execution gap — the exact surface where deliberation becomes irreversible action. The 0→1 Doctrine closes that surface before execution. Not after.

“The Magna Carta did not stop kings. It established that certain actions require prior authorisation. The 0→1 Doctrine proposes the same principle for every consequential AI decision.”

Not a product. Not a sector. A constitutional layer — formally filed before the era it governs. The architecture is not built for today. It is built for what follows.

Authorized Intelligence — 2026

The world has AI clinical decision support. It does not yet have Authorized Intelligence — an AI system that cannot prescribe, diagnose, or administer without a pre-execution receipt confirming the action was checked against published clinical authorities. The 0→1 Doctrine is the first formally specified architecture for that requirement. Healthcare is the second domain. The law is domain-agnostic.

Black Box → Proof Paper — 2027–2030

AI systems today are black boxes: inputs go in, outputs come out, no one can verify what happened inside. The ACR is the clinical proof paper that replaces the black box. Every parameter checked. Every gate result. Every authority cited. Sealed before execution. A hallucination that produces a PROCEED outcome still leaves a sealed clinical ACR proving what the agent was authorised to prescribe. The gate is the answer to the hallucination problem.

If an AI is 99% sure, the 1% risk is where the world gets destroyed by a superhuman agent.

The pre-execution gate is not a constraint on AI capability. It is the proof that capability was exercised within authorised bounds. Every consequential AI action — financial, medical, logistical, legal, physical — will eventually require a pre-execution receipt. The only question is whether that receipt is architecturally guaranteed or aspirationally hoped for.

Artificial General Intelligence — 2030s

When a single AI system can perform any intellectual task a human can, every consequential decision it makes risks irreversible consequence. The 0→1 Doctrine does not govern the intelligence — it governs the action. No band intersection, no ACR, no execution. The architecture is capability-agnostic. An AGI operating at ten times human intelligence still cannot execute a prescription past a breached clinical band. Governance complexity does not increase with AI capability. The four-line rule is invariant.

Agentic Swarms & Dark Data — 2030s

When millions of AI agents operate in coordination — each delegating to others, each triggering consequential actions — the governance chain becomes non-linear. Dark data — the unconsented, unstructured, unaudited data that trains and fuels AI systems at scale — becomes the primary governance risk. The 0→1 Doctrine applies to every agent node: each handoff requires its own band intersection check and its own ACR. A chain of 100 agents produces 100 receipts. Accountability cannot be laundered through delegation depth. Delete Before Share ensures the chain holds receipts, not raw data. At 1 billion transactions per day: no biometrics, no identities, no dark data in the governance store.

Artificial Superintelligence — 2035–2045

An ASI that exceeds human intelligence in every domain is the central concern of existential risk research. The 0→1 Doctrine does not claim to eliminate this risk. It proposes one formally specified constraint: no consequential clinical action without a pre-execution receipt confirming authorisation was checked against human-declared parameters. An ASI operating inside this architecture cannot act without that receipt — regardless of how far beyond human intelligence it operates. The constraint is constitutional, not computational. The architecture closes the pre-execution accountability gap: the specific surface where an ASI transitions from deliberation to irreversible action.

Quantum Computing — 2035–2050 — Architecture designed for this transition

A quantum computer operating on qubits normalises probability amplitudes to [0,1] — the same range as the governance band. The architecture was designed with this in mind: 0 and 1 are the only numbers that survive the analogue, classical, and quantum eras. Token signatures use lattice-based post-quantum cryptography (NIST FIPS 204, ML-DSA). The ACR is quantum-resilient by design, not by adaptation — filed before quantum advantage breaks classical cryptography.

Every ACR receipt issued today remains tamper-evident even when quantum computers can break current encryption. The architecture was designed for that transition — filed before it arrives. The receipts do not need to be reissued. The governance record is already quantum-resilient.
NIST FIPS 204 · ML-DSA · CRYSTALS-Kyber · filed pre-transition · PCT/IN2025/051943
Key exchange
CRYSTALS-Kyber
ACR sealed before quantum breaks classical crypto
Critical medicines — supply chain governance
Every critical medicine in the supply chain is a governance chain. Temperature bands, cold chain compliance, expiry verification, counterfeit detection — each a MAT gate before dispensing authorisation. The same architecture. The same receipt. No medicine past a breached band.
WHO patient safety · OECD Economics of Medication Safety 2022 · $54B OECD avoidable admissions · architecture domain-agnostic
Accident Prevention — the convergence problem
Every major air accident involves parameter convergence — crew fatigue, weather, maintenance status, and fuel load breaching limits simultaneously. No system has ever visualised that convergence before administration. PRAT + EMERGE compute it. The gate fires before the treatment moves. A new class of visualisation — parameter convergence mapping — becomes possible for the first time.
BEA · NTSB · AAIB investigation data · EMERGE · PRAT · hitherto unconceivable pre-administration convergence view
Hospital formulary governance
Formulary inclusion, price bands, equivalence checks, cold chain compliance, safety signal monitoring — each is a band with a published authority range. Each a PRAT parameter. The first architecture to govern the full formulary governance surface before any treatment is approved for use.
WHO EML · NICE formulary · MHRA · BNF · OECD Economics of Medication Safety 2022
The Singularity — 2045–2050+

The technological singularity — the point beyond which intelligence improvement becomes self-sustaining and incomprehensible to humans — is not claimed to be stopped by this architecture. It is proposed to be governed. As intelligence recursively improves itself, every consequential action still passes through the same pre-execution gate. The receipt chain does not become incomprehensible with the intelligence. It remains sealed, auditable, human-readable, and constitutionally prior to execution.

The 0→1 Doctrine files that architecture first. Across six continents. Before the era that requires it.

PCT/IN2025/051943 · US 19/489,595 · IN 202511115781 · Priority: 23 November 2025 · Vatsal Soin
◯ MODEL LAB
Foundation Model Compatibility Lab
The same 9-token governance chain runs identically across every foundation model. The doctrine never changes. Only the AI beneath it changes. Clinical scenario auto-loaded from this demo. Add API keys for live mode or run in demo mode instantly.
PCT/IN2025/051943 · Vatsal Soin · Priority: 23 November 2025

0→1 Doctrine
Foundation Model
Compatibility Lab

The same governance chain — USP · UCC · MAT · SFS · ACR · OCT — runs identically across every foundation model. The doctrine does not change. Only the AI beneath it changes.

Vatsal Soin · PCT/IN2025/051943 · Priority: 23 November 2025

How the doctrine sits above every model
Your request
USP · UCC · MAT · SFS · ACR · OCT
Claude Sonnet 4.6
The doctrine never changes. Only the model below it changes.
Import from sector demo
🏥 This demo
Governed Claude — Live AI Demonstration
The full governance chain has now run. The OCT instruction is live. Watch what changes when Claude operates under that instruction versus without any governance at all.
● DEMO MODE — mock responses · no API key required
Question sent to both Claude instances:
Disclaimer
This demonstration uses Claude Sonnet 4.6 via the Anthropic API. In Live Mode, your API key is used solely for this request and never stored. The governed vs ungoverned comparison is a conceptual demonstration of the 0→1 Doctrine architecture (PCT/IN2025/051943). Mock responses in Demo Mode are illustrative only. Real governance deployments require full chain integration.